Consun Pharmaceutical Group Limited (FRA:C1P)
Germany
· Delayed Price · Currency is EUR 0.9250
-0.2650 (-22.27%)
Last updated: May 14, 2025
FRA:C1P Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 901 | 842 | 438 | 383 | 394 | 257 | Upgrade
|
| Market Cap Growth | 92.35% | 92.35% | 14.25% | -2.77% | 53.22% | -42.71% | Upgrade
|
| Enterprise Value | 498 | 471 | 146 | 147 | 240 | 184 | Upgrade
|
| Last Close Price | 1.19 | 1.03 | 0.47 | 0.38 | 0.36 | 0.22 | Upgrade
|
| PE Ratio | 7.48 | 6.99 | 4.37 | 4.14 | 4.82 | 4.12 | Upgrade
|
| PS Ratio | 2.30 | 2.14 | 1.33 | 1.21 | 1.39 | 1.17 | Upgrade
|
| PB Ratio | 1.55 | 1.45 | 0.88 | 0.82 | 0.98 | 0.82 | Upgrade
|
| P/TBV Ratio | 1.78 | 1.66 | 1.03 | 1.00 | 1.25 | 1.11 | Upgrade
|
| P/FCF Ratio | 6.96 | 6.51 | 4.48 | 3.15 | 4.54 | 2.51 | Upgrade
|
| P/OCF Ratio | 6.27 | 5.85 | 4.19 | 2.98 | 3.92 | 2.37 | Upgrade
|
| EV/Sales Ratio | 1.37 | 1.20 | 0.44 | 0.46 | 0.85 | 0.84 | Upgrade
|
| EV/EBITDA Ratio | 3.92 | 3.45 | 1.27 | 1.38 | 2.38 | 2.37 | Upgrade
|
| EV/EBIT Ratio | 4.18 | 3.65 | 1.38 | 1.51 | 2.63 | 2.67 | Upgrade
|
| EV/FCF Ratio | 3.85 | 3.64 | 1.49 | 1.21 | 2.77 | 1.79 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.06 | 0.13 | 0.13 | 0.21 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | 0.26 | 0.26 | 0.57 | 0.58 | 0.83 | 0.88 | Upgrade
|
| Debt / FCF Ratio | 0.27 | 0.27 | 0.67 | 0.51 | 0.97 | 0.67 | Upgrade
|
| Asset Turnover | 0.52 | 0.52 | 0.50 | 0.51 | 0.49 | 0.46 | Upgrade
|
| Inventory Turnover | 2.07 | 2.07 | 1.99 | 2.12 | 2.13 | 1.97 | Upgrade
|
| Quick Ratio | 3.09 | 3.09 | 2.60 | 2.47 | 2.06 | 1.80 | Upgrade
|
| Current Ratio | 3.32 | 3.32 | 2.86 | 2.68 | 2.25 | 2.00 | Upgrade
|
| Return on Equity (ROE) | 22.07% | 22.07% | 21.38% | 21.53% | 21.64% | 19.98% | Upgrade
|
| Return on Assets (ROA) | 10.73% | 10.73% | 9.93% | 9.66% | 9.93% | 8.98% | Upgrade
|
| Return on Capital (ROIC) | 13.41% | 13.41% | 12.39% | 12.05% | 12.53% | 11.60% | Upgrade
|
| Return on Capital Employed (ROCE) | 21.80% | 21.80% | 20.60% | 20.20% | 22.00% | 21.00% | Upgrade
|
| Earnings Yield | 13.37% | 14.31% | 22.87% | 24.18% | 20.73% | 24.28% | Upgrade
|
| FCF Yield | 14.36% | 15.37% | 22.34% | 31.73% | 22.03% | 39.84% | Upgrade
|
| Dividend Yield | 11.24% | 7.24% | 11.20% | 9.59% | 9.39% | 13.59% | Upgrade
|
| Payout Ratio | 74.75% | 74.75% | 41.59% | 18.67% | 33.56% | 26.36% | Upgrade
|
| Buyback Yield / Dilution | -4.12% | -4.12% | -0.91% | 1.58% | 1.54% | 4.35% | Upgrade
|
| Total Shareholder Return | 7.12% | 3.12% | 10.29% | 11.17% | 10.92% | 17.95% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.